Epstein-Barr Virus and Cancer Risks
Prospective Cohort Study on Epstein-Barr Virus Antibody and Cancer Risks
Sun Yat-sen University
100,000 participants
Aug 1, 2008
OBSERVATIONAL
Conditions
Summary
The goal of this prospective cohort study is to investigate the associations between Epstein-Barr Virus (EBV) antibody levels and the risk of overall and site-specific cancer types in Southern China. The main questions it aims to answer are: Question 1: In addition to the established EBV-associated cancer types, such as lymphomas, nasopharyngeal carcinoma, and stomach cancer, whether EBV is associated with other cancer types? Question 2: What's the cancer burden attributed to EBV in Southern China?
Eligibility
Inclusion Criteria3
- Subject residents in Zhongshan or Wuzhou City;
- Subject has no medical record of prevalent cancer;
- Subject has psychical condition and well consciousness, and willingness to accept and cooperate with the study\'s follow-up procedures.
Exclusion Criteria2
- Subject has heavy cardiovascular, liver, or kidney disease;
- Subject has prevalent cancer.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Participants underwent several EBV antibody tests, including VCA-IgA, EBNA1-IgA, etc.
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06203314